Stock News

Columbia Partners Investment Management Upped By $722,952 Its Citigroup (C) Position; Clough Capital Partners LP Has Boosted Pacira Pharmaceuticals (PCRX) Stake By $6.08 Million

Clough Capital Partners LP increased Pacira Pharmaceuticals Inc (PCRX) stake by 842.56% reported in 2017Q3 SEC filing. Clough Capital Partners LP acquired 164,300 shares as Pacira Pharmaceuticals Inc (PCRX)’s stock rose 10.53%. The Clough Capital Partners LP holds 183,800 shares with $6.90M value, up from 19,500 last quarter. Pacira Pharmaceuticals Inc now has $1.24 billion valuation. The stock increased 1.33% or $0.4 during the last trading session, reaching $30.55. About 845,719 shares traded. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since February 23, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Columbia Partners Llc Investment Management increased Citigroup Inc (C) stake by 50% reported in 2017Q3 SEC filing. Columbia Partners Llc Investment Management acquired 10,041 shares as Citigroup Inc (C)’s stock rose 1.55%. The Columbia Partners Llc Investment Management holds 30,122 shares with $2.19M value, up from 20,081 last quarter. Citigroup Inc now has $196.00B valuation. The stock decreased 0.95% or $0.73 during the last trading session, reaching $76.27. About 16.05 million shares traded. Citigroup Inc. (NYSE:C) has risen 35.60% since February 23, 2017 and is uptrending. It has outperformed by 18.90% the S&P500.

Since December 15, 2017, it had 0 buys, and 2 insider sales for $1.18 million activity. Riker Lauren Bullaro had sold 340 shares worth $14,858. On Wednesday, January 10 STACK DAVID M sold $1.16 million worth of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) or 28,885 shares.

Investors sentiment decreased to 1.39 in 2017 Q3. Its down 0.23, from 1.62 in 2017Q2. It fall, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Hightower Advsrs Ltd Com invested 0% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Marsico Capital Mgmt Limited Liability Co reported 0.06% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Point72 Asset Mgmt Lp holds 0.18% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) or 1.08M shares. 1,909 were accumulated by Envestnet Asset Management Inc. Consonance Cap Mngmt Ltd Partnership holds 5.73% or 1.38 million shares in its portfolio. Point72 Asia (Hong Kong) Limited has 110 shares. Avenir owns 12,120 shares for 0.04% of their portfolio. Gp One Trading Lp holds 10,423 shares. Alyeska Inv Grp Incorporated Lp invested in 0.19% or 638,943 shares. Pacad Inv Limited holds 0.02% or 2,300 shares in its portfolio. State Of Wisconsin Board has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Tower Ltd Co (Trc) reported 7,335 shares stake. Granahan Inv Ma stated it has 0.53% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Ameriprise holds 290,278 shares or 0.01% of its portfolio. 32,624 were reported by Riverpark Advsr Ltd Limited Liability Company.

Among 22 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pacira Pharmaceuticals had 89 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has “Neutral” rating given on Monday, August 21 by Janney Capital. The company was maintained on Thursday, October 19 by Needham. Mizuho initiated the shares of PCRX in report on Tuesday, April 19 with “Buy” rating. The rating was downgraded by Brean Capital to “Hold” on Friday, July 1. RBC Capital Markets maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) rating on Wednesday, October 11. RBC Capital Markets has “Buy” rating and $54.0 target. Wedbush maintained it with “Buy” rating and $80.0 target in Wednesday, December 20 report. Canaccord Genuity maintained the shares of PCRX in report on Monday, January 29 with “Hold” rating. Canaccord Genuity maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Thursday, February 15 with “Hold” rating. The rating was maintained by Canaccord Genuity on Monday, October 2 with “Buy”. Wedbush maintained the stock with “Buy” rating in Monday, November 20 report.

Clough Capital Partners LP decreased Logmein Inc (NASDAQ:LOGM) stake by 6,110 shares to 124,424 valued at $13.69 million in 2017Q3. It also reduced Blackstone Mtg Tr Inc (NYSE:BXMT) stake by 87,900 shares and now owns 1.17M shares. Starwood Ppty Tr Inc (NYSE:STWD) was reduced too.

Among 40 analysts covering Citigroup Inc. (NYSE:C), 19 have Buy rating, 3 Sell and 18 Hold. Therefore 48% are positive. Citigroup Inc. had 116 analyst reports since July 21, 2015 according to SRatingsIntel. Sandler O’Neill maintained Citigroup Inc. (NYSE:C) rating on Tuesday, January 16. Sandler O’Neill has “Buy” rating and $89.0 target. Stifel Nicolaus downgraded Citigroup Inc. (NYSE:C) on Monday, October 9 to “Hold” rating. The stock has “Buy” rating by Renaissance Macro Securities LLC on Sunday, July 16. Keefe Bruyette & Woods upgraded Citigroup Inc. (NYSE:C) on Wednesday, April 5 to “Outperform” rating. Oppenheimer maintained Citigroup Inc. (NYSE:C) rating on Tuesday, January 5. Oppenheimer has “Perform” rating and $73.0 target. The stock has “Buy” rating by SunTrust on Monday, August 24. The stock has “Buy” rating by Vertical Group on Tuesday, September 5. The firm has “Hold” rating given on Thursday, August 6 by Vetr. The rating was maintained by Jefferies on Tuesday, January 16 with “Hold”. Raymond James initiated the shares of C in report on Tuesday, October 31 with “Hold” rating.

Investors sentiment increased to 1.35 in 2017 Q3. Its up 0.25, from 1.1 in 2017Q2. It improved, as 56 investors sold C shares while 400 reduced holdings. 125 funds opened positions while 492 raised stakes. 2.04 billion shares or 0.42% more from 2.03 billion shares in 2017Q2 were reported. Massachusetts Financial Ser Company Ma stated it has 33.48 million shares or 1.06% of all its holdings. L And S Incorporated has invested 1.06% in Citigroup Inc. (NYSE:C). Cullen Capital Mngmt Llc, New York-based fund reported 17,100 shares. Srb accumulated 2,669 shares or 0.03% of the stock. Guyasuta Invest Advsrs Inc accumulated 9,625 shares or 0.08% of the stock. River And Mercantile Asset Mgmt Llp holds 11.8% or 1.09M shares in its portfolio. United Capital Financial Advisers Ltd Liability reported 178,935 shares. Kazazian Asset Mgmt Lc has 50,431 shares for 4.49% of their portfolio. Hourglass Cap Lc holds 213,964 shares. Reilly Financial Advsrs Limited Liability reported 1,782 shares stake. Pathstone Family Office Ltd Llc owns 13 shares. Boston Advsr Limited Company holds 0.88% or 533,331 shares in its portfolio. D E Shaw & Communication holds 0.08% or 728,528 shares. Ftb Advsr holds 18,544 shares or 0.14% of its portfolio. Parallax Volatility Advisers Lp has 0.16% invested in Citigroup Inc. (NYSE:C) for 1.34 million shares.

Leave a Reply

Your email address will not be published. Required fields are marked *